Evidence map›Paper›PMID 31837339›Full record

ReviewFrontiers in neuroendocrinology2020

The promises and pitfalls of sex difference research.

Liisa A M Galea, Elena Choleris, Arianne Y K Albert, Margaret M McCarthy, Farida Sohrabji

Abstract readReview
In one paragraph

Review in Frontiers in neuroendocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liisa A M GaleaDepartment of Psychology, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC V6T1Z3, Canada. Electronic address: liisa.galea@ubc.ca.
Elena CholerisDepartment of Psychology and Neuroscience Program, University of Guelph, Guelph, ON N1G 2W1, Canada.
Arianne Y K AlbertWomen's Health Research Institute of British Columbia, Vancouver, BC, Canada.
Margaret M McCarthyJames and Carolyn Frenkil Dean's Professor and Chair, Dept of Pharmacology, Univ of Maryland School of Medicine, Baltimore, MD, United States.
Farida SohrabjiWomen's Health in Neuroscience Program, Department of Neuroscience and Experimental Therapeutics, Texas A&M HSC College of Medicine, Bryan, TX 77807, United States.

Funding

Neuroinflammation, Epigenetics and Male VulnerabilityR01MH052716 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI MARGARET M. MCCARTHY · 2000 to 2026
$9.6M
Endocannabinoids regulate microglia in developing brainR01DA039062 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI MARGARET M. MCCARTHY · 2016 to 2026
$4.2M
Epigenetics of the Aging Astrocyte: Implications for StrokeR01AG042189 · NIA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Farida Sohrabji · 2011 to 2026
$3.1M
Epigenetics of the Aging Astrocyte: Implications for StrokeRF1AG042189 · NIA · TEXAS A&M UNIVERSITY · PI SOHRABJI, FARIDA · 2018 to 2018
$2.8M
Targeting the gut for stroke neuroprotection; IGF-1 modulation of the blood-gut barrierRF1NS119872 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI BAKE, SHAMEENA, SOHRABJI, FARIDA · 2022 to 2022
$1.7M
Neuroprotection in the Aging Female BrainR01NS074895 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SOHRABJI, FARIDA · 2011 to 2015
$1.7M
Neuroprotection in the aging female brainR56NS074895 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SOHRABJI, FARIDA · 2017 to 2017
$520k
NIA NIH HHS R01 AG042189NIA NIH HHS RF1 AG042189NIDA NIH HHS R01 DA039062NIMH NIH HHS R01 MH052716NINDS NIH HHS R01 NS074895NINDS NIH HHS R56 NS074895NINDS NIH HHS RF1 NS119872
6 · The paper itself

Abstract

Funding agencies in North America and Europe are recognizing the importance of the integration of sex differences into basic and clinical research. Although these mandates are in place to improve our knowledge of health for both men and women, there have been a number of implementation issues that require vigilance on the part of funders and the research community. Here we discuss issues on simple inclusion of both sexes in studies to specialisation of sex differences with attention paid to statistics and the need for sex-specific treatments. We suggest differing mandates need to be considered regarding simple integration versus the need for studies in the specialisation of sex differences and/or the need for research that recognises the importance of male-specific or female-specific factors that influence subsequent health such as menstruation, menopause or pregnancy.

Indexed as

Sex CharacteristicsSex FactorsAnimalsBiomedical ResearchCanadaFemaleHumansMaleNational Institutes of Health (U.S.)Research Support as TopicUnited StatesWomen's HealthFemalesFundingImplementationMalesSABVSample sizeSex differencesSGBAStatistics

Identifiers

PMID31837339
PMCPMC7050281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.